-
DE
Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that break down components of the extracellular matrix and play a key role in tissue remodeling, inflammation, and cancer.
Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that break down components of the extracellular matrix and play a key role in tissue remodeling, inflammation, and cancer.
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases – enzymes that cleave protein molecules at specific internal sites. Their defining characteristic is the ability to degrade components of the extracellular matrix (ECM), the complex network of proteins and polysaccharides that surrounds, supports, and connects cells throughout the body. Through this activity, MMPs play a fundamental role in a wide range of biological processes.
More than 20 different MMPs have been identified in humans. They are classified into subgroups based on their preferred substrates, including collagenases, gelatinases, stromelysins, and membrane-type MMPs (MT-MMPs). All MMPs share a conserved zinc ion in their active site, which is essential for their enzymatic function.
MMPs are involved in numerous physiological (normal) and pathological (disease-related) processes:
Because MMPs are highly potent enzymes, their activity is tightly controlled at multiple levels:
Excess or uncontrolled MMP activity is associated with a wide range of diseases:
MMPs play a central role in tumor invasion and metastasis. By degrading the extracellular matrix, they allow cancer cells to infiltrate surrounding tissues and travel via the blood or lymphatic system to distant organs. MMP-2 and MMP-9 (gelatinases) are elevated in many types of cancer and are among the most extensively studied MMPs in oncology.
In chronic inflammatory conditions such as rheumatoid arthritis or inflammatory bowel disease (IBD), excessive MMP activity leads to the progressive destruction of cartilage and bone tissue.
MMPs contribute to the destabilization of atherosclerotic plaques in arterial walls and are involved in the pathological remodeling of the heart muscle that occurs in heart failure.
In diseases such as multiple sclerosis, Alzheimer disease, and following stroke, MMPs contribute to the disruption of the blood-brain barrier and to neuronal tissue degradation.
Both insufficient and excessive MMP activity can impair wound healing. In fibrosis (pathological accumulation of connective tissue), MMP activity is often too low to adequately degrade excess collagen, leading to tissue scarring.
Certain MMPs are investigated as biomarkers in clinical diagnostics. Elevated MMP levels in blood, urine, or tissue samples may indicate tumor activity, inflammatory processes, or cardiovascular risk. For example, MMP-9 is being studied as a potential biomarker for myocardial infarction risk.
Inhibiting MMPs has long been considered a promising therapeutic strategy, particularly in oncology. However, clinical trials with MMP inhibitors (MMPIs) have yielded mixed results, largely because MMPs can have both harmful and protective roles depending on the disease context. Current research focuses on developing more selective inhibitors targeting specific MMP subtypes to reduce side effects.
In dentistry, MMP inhibitors such as low-dose doxycycline are already used clinically, for instance in the treatment of periodontitis.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.